Drugs for the heart 8th Edition PDF
Drugs for the heart 8th Edition PDF disease is destined to become an even more important cause of morbidity and mortality as the population of the so-called developed world ages and the epidemic of ischemic heart disease in
more affluent and more obese persons in the developing world sets in.
Fortunately, an ever-growing array of drugs that act on the cardiovascu-
lar system continues to become available. These agents are more effica-
cious and better tolerated than their predecessors, not only in the
management of established disease but also increasingly in prevention.
However, both trainees and practitioners of medicine and cardiology
have ever-increasing difficulty in deciding how to choose the proper therapies for their patients. The eighth edition of Professors Opie’s and Gersh’s important book provides a rational approach to help with these important decisions. Drugs for the Heart is a concise yet complete
presentation of cardiac pharmacology and therapeutics. It presents, in a very readable and eminently understandable fashion, an extraordinary amount of important information on the effects of drugs on the heart and circulation. The editors and the talented authors they have enlisted have the unique ability to explain, in a straightforward manner
and without oversimplification, the mechanism of action of drugs. This
book also summarizes the results of important clinical trials that have shaped regulatory approval and practice guidelines. Finally, it provides
important practical information for the clinician.
The eighth edition of this now well-established and admired book builds on the strengths of its predecessors. The excellent explanatory diagrams (an Opie trademark) are even better and more numerous than in previous editions, while the text and references in this rapidly moving field are as fresh as this week’s journals. For example, since the publica-
tion of the seventh edition the care of patients with many cardiovascular
disorders has advanced considerably, and to describe the new landscape the editors have added several distinguished clinical scientists to their author list. These include John R. Teerlink and Karen Sliwa (heart failure), Henry Krum and Ronald G. Victor (antihypertensive therapies), Stanley Nattel (antiarrhythmic drugs), Harvey White (antithrombotic and
antiplatelet agents), as well as Juris Meier (metabolic syndrome and
diabetes). When these new authors are added to the experts continuing
from the earlier edition, this makes a truly outstanding global team. I strongly recommend this concise volume, which will be of enormous value and interest to all clinicians—specialists and generalists, as well as trainees at all levels, teachers and scientists—who wish to gain
a clear understanding of contemporary cardiovascular pharmacology and apply this information most effectively to the care of patients with cardiovascular disease.